Shopping Cart
Remove All
Your shopping cart is currently empty
Glarivibart
Copy Product Info
😃Good
Catalog No. T9901A-1903Cas No. 3033697-08-1
Glarivibart is a humanized IgG1κ monoclonal antibody inhibitor that targets the fusion F protein (RSV-F) of respiratory syncytial virus (RSV). It exhibits significant antiviral activity and is applicable for RSV infection research.
Glarivibart
Glarivibart
Copy Product Info😃Good
Catalog No. T9901A-1903Cas No. 3033697-08-1
Glarivibart is a humanized IgG1κ monoclonal antibody inhibitor that targets the fusion F protein (RSV-F) of respiratory syncytial virus (RSV). It exhibits significant antiviral activity and is applicable for RSV infection research.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | Inquiry | Inquiry | Inquiry | |
| 5 mg | Inquiry | Inquiry | Inquiry |
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Resource Download
Product Introduction
Bioactivity
Chemical Properties
Storage & Solubility Information
| Description | Glarivibart is a humanized IgG1κ monoclonal antibody inhibitor that targets the fusion F protein (RSV-F) of respiratory syncytial virus (RSV). It exhibits significant antiviral activity and is applicable for RSV infection research. |
| Cas No. | 3033697-08-1 |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Calculator
Preview
Related Tags: buy Glarivibart | purchase Glarivibart | Glarivibart cost | order Glarivibart
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.